Five facility certificates published
Certification Assurance International issued Lyotek Labs five facility certificates on 27 October 2026, and all of them are now published on this site as the issuer's PDFs.
All press releases
Lyotek research peptides now reach more than 170 countries
Through its exclusive distributor, Lyotek research peptides now reach laboratories in more than 170 countries from the laboratory in Switzerland.
The milestone follows a year in which our distributor has extended its coverage region by region. Every vial it supplies still comes from a lot released by the same laboratory, with the certificate of analysis for that lot.
Reaching this many countries changes the paperwork more than the product. Our distributor prepares the export documents for each destination before a shipment leaves, so a consignment does not wait at a border for a missing form.
Laboratories that want to know whether our vials can reach their country, or how to order there, can ask us through the contact page.
Lyotek products are supplied for research use only.
More from the laboratory
Our exclusive distributor expands to the Middle East, Southeast Asia and Latin America
Lyotek's exclusive distributor has extended its coverage to three new regions, which brings local support to laboratories there.
Growth hormone axis range opens with Tesamorelin, CJC-1295 and Ipamorelin
Three research peptides open a new section of the Lyotek catalogue: Tesamorelin at 20 mg, and CJC-1295 and Ipamorelin at 10 mg each.